Volkmar Henschel

8.4k total citations · 4 hit papers
44 papers, 5.5k citations indexed

About

Volkmar Henschel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Volkmar Henschel has authored 44 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Volkmar Henschel's work include Advanced Breast Cancer Therapies (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and HER2/EGFR in Cancer Research (6 papers). Volkmar Henschel is often cited by papers focused on Advanced Breast Cancer Therapies (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and HER2/EGFR in Cancer Research (6 papers). Volkmar Henschel collaborates with scholars based in Germany, Switzerland and United States. Volkmar Henschel's co-authors include Carlos H. Barrios, Véronique Dièras, Leisha A. Emens, Sherene Loi, Sylvia Adams, Eric P. Winer, Hiroji Iwata, Hope S. Rugo, Luciana Molinero and Peter Schmid and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Volkmar Henschel

44 papers receiving 5.5k citations

Hit Papers

4 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

2018 3.0k citations Peter Schmid, Sylvia Adams et al. profile →
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial

2019 846 citations Peter Schmid, Hope S. Rugo et al. The Lancet Oncology profile →
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial

2015 462 citations Alice T. Shaw, Leena Gandhi et al. The Lancet Oncology profile →
First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis

2021 293 citations Leisha A. Emens, Sylvia Adams et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Volkmar Henschel Germany	21	4.0k	1.9k	1.3k	1.2k	967	44	5.5k
Raanan Berger Israel	34	4.2k 1.0×	1.9k 1.0×	1.6k 1.3×	1.2k 0.9×	2.2k 2.2×	160	7.2k
Andrea Wang‐Gillam United States	38	5.9k 1.5×	1.3k 0.7×	2.9k 2.2×	1.5k 1.2×	1.9k 1.9×	195	8.1k
Tom Dønnem Norway	42	3.1k 0.8×	1.8k 0.9×	1.6k 1.2×	1.8k 1.4×	2.3k 2.4×	106	5.7k
Ravit Geva Israel	33	4.1k 1.0×	1.6k 0.9×	1.2k 0.9×	827 0.7×	822 0.9×	134	5.3k
Junzo Hamanishi Japan	33	4.4k 1.1×	965 0.5×	3.6k 2.8×	873 0.7×	1.7k 1.7×	142	7.4k
Robert D. Loberg United States	34	2.1k 0.5×	920 0.5×	1.0k 0.8×	832 0.7×	1.6k 1.6×	59	4.1k
Shom Goel United States	25	3.1k 0.8×	1.8k 0.9×	933 0.7×	1.5k 1.2×	2.3k 2.3×	71	5.8k
Niels Reinmuth Germany	43	5.0k 1.2×	2.9k 1.5×	851 0.7×	1.5k 1.2×	2.9k 3.0×	196	7.9k
William Jacot France	34	2.7k 0.7×	1.4k 0.7×	433 0.3×	1.2k 1.0×	1.1k 1.1×	224	4.2k
Anne F. Schott United States	32	4.4k 1.1×	898 0.5×	952 0.7×	2.5k 2.1×	2.4k 2.5×	92	7.0k

Countries citing papers authored by Volkmar Henschel

Since Specialization

Citations

This map shows the geographic impact of Volkmar Henschel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volkmar Henschel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volkmar Henschel more than expected).

Fields of papers citing papers by Volkmar Henschel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volkmar Henschel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volkmar Henschel. The network helps show where Volkmar Henschel may publish in the future.

Co-authorship network of co-authors of Volkmar Henschel

This figure shows the co-authorship network connecting the top 25 collaborators of Volkmar Henschel. A scholar is included among the top collaborators of Volkmar Henschel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volkmar Henschel. Volkmar Henschel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huober, Jens, Carlos H. Barrios, Naoki Niikura, et al.. (2022). Atezolizumab With Neoadjuvant Anti–Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial. Journal of Clinical Oncology. 40(25). 2946–2956. 82 indexed citations

Emens, Leisha A., Sylvia Adams, Carlos H. Barrios, et al.. (2021). First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis. Annals of Oncology. 32(8). 983–993. 293 indexed citations breakdown →

Emens, Leisha A., Sylvia Adams, Carlos H. Barrios, et al.. (2020). LBA16 IMpassion130: Final OS analysis from the pivotal phase III study of atezolizumab + nab-paclitaxel vs placebo + nab-paclitaxel in previously untreated locally advanced or metastatic triple-negative breast cancer. Annals of Oncology. 31. S1148–S1148. 44 indexed citations

Iwata, Hitoshi, Leisha A. Emens, Sylvia Adams, et al.. (2020). 49MO IMpassion130: Final OS analysis from the pivotal phase III study of atezolizumab + nab-paclitaxel vs placebo + nab-paclitaxel in previously untreated locally advanced or metastatic triple-negative breast cancer. Annals of Oncology. 31. S1261–S1262. 8 indexed citations

Schmid, Peter, Hope S. Rugo, Sylvia Adams, et al.. (2019). Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology. 21(1). 44–59. 846 indexed citations breakdown →

Schmid, Peter, Sylvia Adams, Hope S. Rugo, et al.. (2018). IMpassion130: Results from a global, randomised, double-blind, phase III study of atezolizumab (atezo) + nab-paclitaxel (nab-P) vs placebo + nab-P in treatment-naive, locally advanced or metastatic triple-negative breast cancer (mTNBC). Annals of Oncology. 29. viii707–viii708. 9 indexed citations

Shaw, Alice T., Leena Gandhi, Shirish M. Gadgeel, et al.. (2015). Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial. The Lancet Oncology. 17(2). 234–242. 462 indexed citations breakdown →

Henschel, Volkmar & Ulrich Mansmann. (2013). Iterated Convex Minorant Algorithm for interval censored eventdata. 6 indexed citations

Birrer, M. J., Heather A. Lankes, Robert A. Burger, et al.. (2012). Biomarker (BM) Results from GOG-0218, a Phase 3 Trial of Front-Line Bevacizumab (BV) + Chemotherapy (CT) for Ovarian Cancer (OC). Annals of Oncology. 23. ix81–ix82. 9 indexed citations

10.

Kühnisch, Jan, Katharina Bücher, Volkmar Henschel, et al.. (2010). Diagnostic performance of the universal visual scoring system (UniViSS) on occlusal surfaces. Clinical Oral Investigations. 15(2). 215–223. 42 indexed citations

11.

Henschel, Volkmar, et al.. (2010). Encapsulation of ethylhexyl methoxycinnamate, a light-sensitive UV filter, in lipid nanoparticles. Journal of Microencapsulation. 27(8). 714–725. 20 indexed citations

12.

Mansmann, Ulrich, et al.. (2010). Bilanz der Qualitätssicherung ambulanter Koloskopien nach 245.000 Untersuchungen. 28(3). 63–68. 2 indexed citations

13.

Stülpnagel, Celina von, Peter Reilich, Andreas Straube, et al.. (2009). Myofascial Trigger Points in Children With Tension-Type Headache: A New Diagnostic and Therapeutic Option. Journal of Child Neurology. 24(4). 406–409. 29 indexed citations

14.

Henschel, Volkmar, et al.. (2009). In vitro evaluation of the cutaneous penetration of sprayable sunscreen emulsions with high concentrations of UV filters. International Journal of Cosmetic Science. 31(4). 279–292. 49 indexed citations

15.

Schmitter, Marc, et al.. (2008). Validity of temporomandibular disorder examination procedures for assessment of temporomandibular joint status. American Journal of Orthodontics and Dentofacial Orthopedics. 133(6). 796–803. 27 indexed citations

16.

Mansmann, Ulrich, et al.. (2008). Epidemiology and Quality Control of 245 000 Outpatient Colonoscopies. Deutsches Ärzteblatt international. 105(24). 434–40. 24 indexed citations

17.

Eisenhardt, Steffen U., Volkmar Henschel, Ariane Germeyer, et al.. (2006). Early Effects of Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 91(3). 946–952. 88 indexed citations

18.

Henschel, Volkmar & Wolf‐Dieter Richter. (2002). Geometric Generalization of the Exponential Law. Journal of Multivariate Analysis. 81(2). 189–204. 12 indexed citations

19.

Henschel, Volkmar. (2002). Statistical inference in simplicially contoured sample distributions. Metrika. 56(3). 215–228. 3 indexed citations

20.

Henschel, Volkmar. (2001). Exact distributions in the model of a regression line for the threshold parameter with exponential distribution of errors. Kybernetika. 37(6). 703–723. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact